The 2nd International mRNA Health Conference

rna-seq

The time is right to give therapeutic mRNA a special forum.

mRNA – the molecule whose medical use seemed almost out of reach until a few years ago – is now in substantial progress to become a new class of drugs. mRNA may transform the treatment of many human diseases and disorders.

The 2nd International mRNA Health Conference, which will be held on November 11 and 12, 2014, in Cambridge, Massachusetts, will bring together more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions. During the two-day event, colleagues from around the world will share the vanguard of research and technologies poised to unlock the tremendous medical potential of mRNA for many therapeutic indications.

Conference Program

Tuesday, November 11th

8:00 am Opening registration and reception
9:00 am Welcome remarks by the Organizing Committee

Introductory Sessions

9:30 am Jack Szostak, Massachusetts General Hospital, 2009 Nobel Prize in Physiology or Medicine
mRNA and the origin of life
10:00 am John Reynders, Moderna Therapeutics
Is mRNA like software?
10:30 am Phil Sharp, MIT Institute, 1993 Nobel Prize in Physiology or Medicine
Non-coding RNA in the synthesis and regulation of mRNA
11:00 am Coffee Break
11:30 am Ingmar Hoerr, CureVac
Optimizing mRNA for versatile medical approaches
12:00 pm Ugur Sahin, BioNTech
mRNA for Individualized Cancer Immunotherapy
12:30 pm Lunch Break
1:30 pm Session Vaccines
1:30 pm Chair introduction by Ugur Sahin, BioNTech
1:35 pm Andrew Geall, Novartis
2:05 pm Steve Pascolo, University Hospital of Zurich
2:35 pm Ulrike Gnad-Vogt, CureVac
3:05 pm Kris Thielemans, University of Brussels
3:35 pm Coffee Break
3:55 pm Session Therapeutics
3:55 pm Chair introduction by Rahul Kakkar, AstraZeneca
4:00 pm Regina Fritsche-Danielson, AstraZeneca
4:30 pm Ken Chien, Karolinska University
5:00 pm Carsten Rudolph, Ethris
5:30 pm Igor Splawski, Novartis Institutes for BioMedical Research
6:00 pm Session End

Networking Evening State Room Boston

6:15 pm Bus to Reception Dinner
7:00 pm Reception Dinner with Scientific Poster Session

 

Wednesday, November 12, 2014

8:00 am Breakfast
9:00 am Panel Discussion Vaccines
Chaired by: Ugur Sahin, BioNTech
Panelists:
Andrew Geall, Novartis
Steve Pascolo, University Hospital of Zurich
Ulrike Gnad-Vogt, CureVac
Kris Thielemans, University of Brussels
10:00 am Coffee Break
10:30 am Panel Discussion Therapeutics
Chaired by: Stephane Bancel, Moderna Therapeutics
Panelists:
Regina Fritsche-Danielson, AstraZeneca
Ken Chien, Karolinska University
Carsten Rudolph, Ethris
Igor Splawski, Novartis Institutes for BioMedical Research
11:30 am Panel Discussion mRNA Products & Manufacturing
Chaired by: Ingmar Hoerr, CureVac
Panelists:
Steve Harbin, Moderna Therapeutics
Peter Hutt, Former FDA General Counsel
Andreas Kuhn, BioNTech
Anton McCaffrey, TriLink
Florian von der Mülbe, CureVac
12:30 pm Lunch Break
1:30 pm Peter Hutt, Former FDA General Counsel
FDA Regulation of mRNA Biological Drugs
2:00 pm Dan Wattendorf, DARPA
Impact of mRNA on Global Health
2:30 pm Closing remarks by the Organizing Committee
3:00 pm End of conference

Download 2nd International mRNA Health Conference 2014 Program
download PDF

(find out more…)

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Time limit is exhausted. Please reload CAPTCHA.